Distribuzione geografica
Continente #
NA - Nord America 1.427
EU - Europa 1.172
AS - Asia 326
AF - Africa 91
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 2
OC - Oceania 1
Totale 3.023
Nazione #
US - Stati Uniti d'America 1.313
IE - Irlanda 398
CN - Cina 291
IT - Italia 288
UA - Ucraina 162
CA - Canada 112
RU - Federazione Russa 99
CI - Costa d'Avorio 59
DE - Germania 38
SE - Svezia 35
ES - Italia 31
CZ - Repubblica Ceca 30
SN - Senegal 26
GB - Regno Unito 24
FR - Francia 13
IN - India 12
CH - Svizzera 10
VN - Vietnam 9
AT - Austria 7
BE - Belgio 7
GR - Grecia 6
LB - Libano 6
NG - Nigeria 6
PL - Polonia 6
BG - Bulgaria 4
EU - Europa 4
JP - Giappone 4
FI - Finlandia 3
NL - Olanda 3
SK - Slovacchia (Repubblica Slovacca) 3
UZ - Uzbekistan 3
AR - Argentina 1
AU - Australia 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
HU - Ungheria 1
IS - Islanda 1
MX - Messico 1
PT - Portogallo 1
PY - Paraguay 1
SM - San Marino 1
TR - Turchia 1
Totale 3.023
Città #
Dublin 381
Chandler 304
Jacksonville 237
Cambridge 93
Lawrence 93
Andover 91
Nanjing 86
Catania 82
Toronto 80
Des Moines 65
Abidjan 59
Houston 39
Nanchang 32
Boardman 31
Hebei 30
Ottawa 28
Dakar 26
Messina 25
Saint Petersburg 25
Shenyang 22
Tianjin 22
Ashburn 21
Prague 21
Jiaxing 20
Changsha 19
San Mateo 19
Wilmington 18
Barcelona 17
Rome 16
Zhengzhou 9
Jinan 8
Seattle 8
Beijing 7
Brussels 7
Dong Ket 7
Florence 7
Moscow 7
Abuja 6
Berlin 6
Redwood City 6
Bremen 5
Foggia 5
Guangzhou 5
Hangzhou 5
Ningbo 5
Tübingen 5
Falls Church 4
Grafing 4
Irvine 4
Madrid 4
Mumbai 4
Reggio Calabria 4
Vicenza 4
Bolzano 3
Cork 3
Den Haag 3
Frankfurt Am Main 3
Kunming 3
Lappeenranta 3
Liberty Lake 3
Norwalk 3
Taizhou 3
Tappahannock 3
Washington 3
Amiens 2
Avola 2
Brno 2
Cerdanyola del Vallès 2
Fuzhou 2
Hanoi 2
Krakow 2
Leawood 2
London 2
Ludwigshafen 2
Maletto 2
Naples 2
Novokuznetsk 2
Pune 2
Riposto 2
Sereg 2
Sesto Fiorentino 2
Stockholm 2
Tokyo 2
Vienna 2
Ann Arbor 1
Asunción 1
Brantford 1
Budapest 1
Chiba 1
Chioggia 1
Civitavecchia 1
Dearborn 1
Edinburgh 1
Fontebuona 1
Frankfurt am Main 1
Frederick 1
Gava 1
Genova 1
Hanover 1
Hartlepool 1
Totale 2.227
Nome #
Behavioral and neurochemical changes induced by stress-related conditions are counteracted by the neurokinin-2 receptor antagonist saredutant 65
Endocannabinoids and beta-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels 62
Behavioral effects of dietary cholesterol in rats tested in experimental models of mild stress and cognition tasks 58
Different effects of prenatal MAM vs. perinatal THC exposure on regional cerebral blood perfusion detected by Arterial Spin Labelling MRI in rats 57
Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment 57
Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia 56
Altro che Marijuana i molteplici ruoli delle sostanze cannabinoidi endogene 53
Altered responses of dopamine D3 receptor null mice to excitotoxic or anxiogenic stimuli: Possible involvement of the endocannabinoid and endovanilloid systems 52
Dopamine D-3 receptor as a new pharmacological target for the treatment of depression 49
Endocannabinoids and neurodegenerative diseases 47
Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: analyses in patients and perinatal Δ9-tetrahydrocannabinol-exposed rats 46
Beavioral effects of SR 58611A, a beta-3 agonist, on experimental models of mild stress 45
Antidepressant properties of the 5-HT4 receptor partial agonist, SL65.0155: behavioral and neurochemical studies in rats 45
The cannabinoid CB1 antagonist TM38837 with limited penetrance to the brain shows reduced fear-promoting effects in mice 44
Amnesia induced by beta-amyloid fragments is counteracted by cannabinoid CB1 receptor blockade 43
The selective norepinephrine reuptake inhibitor atomoxetine counteracts behavioral impairments in trimethyltin-intoxicated rats 41
Behavioral effects of the β3 adrenoceptor agonist SR58611A: Is it the putative prototype of a new class of antidepressant/anxiolytic drugs? 41
Early modulation of the endocannabinoid tone prevents molecular and behavioral alterations in MAM model of schizophrenia 40
Attuali orientamenti terapeutici della malattia di Parkinson 39
Behavioral effects of saredutant, a tachykinin NK2 receptor antagonist, in experimental models of mood disorders under basal and stress-related conditions 39
Cognitive effects of SL65.0155, a serotonin 5-HT4 receptor partial agonist, in animal models of amnesia 39
Therapeutic potential of cannabinoids in schizophrenia 38
Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels 38
Behavioral modifications induced by dietary cholesterol in rats 38
Reactivity to addictive drugs in the methylazoxymethanol (MAM) model of schizophrenia in male and female rats 37
Biocompatibility of a genetically encoded calcium indicator in a transgenic mouse model 37
Involvement of NK2 receptors in experimental models of anxiety and depression under basal and stress-related conditions 37
The beta3 adrenoceptor agonist, amibegron (SR58611A) counteracts stress-induced behavioral and neurochemical changes 37
Dopamine D(3) receptor knock-out mice exhibit increased behavioral sensitivity to the anxiolytic drug diazepam 36
Behavioral and molecular effects of repeated treatment with citalopram alone or combined with memantine in rats 36
Cannabinoid CB1 receptor blockade effects memory capacity of dopamine D3 KO mice pre-treated with β-amyloid peptide 36
Behavioral effects of ABIO 09/01, a CaMKII inhibitor, on experimental models of depression and anxiety 36
Effects of citalopram combined with memantine in forced swimming test in rats 36
The amnesic effects induced by ßamyloid fragment 1-42 involve cannabinoid neurotransmission in the brain 35
Extinction of avoidance behavior by safety learning depends on endocannabinoid signaling in the hippocampus 34
Long-lasting neurotoxicity of prenatal benzene acute exposure in rats 33
Increased sensitivity to antidepressants of D(3) dopamine receptor-deficient mice in the forced swim test (FST) 33
A preliminary study of endocannabinoid system regulation in psychosis: Distinct alterations of CNR1 promoter DNA methylation in patients with schizophrenia 33
Early Blockade of CB1 Receptors Ameliorates Schizophrenia-like Alterations in the Neurodevelopmental MAM Model of Schizophrenia 33
Melatonin affects the immobility time of rats in the forced swim test: The role of serotonin neurotransmission 32
Enhanced self-administration of the CB1 receptor agonist WIN55,212-2 in olfactory bulbectomized rats: evaluation of possible serotonergic and dopaminergic underlying mechanisms 32
Parkin expression profile in dopamine d3 receptor knock-out mice brains 32
HDAC1 and HDAC3 underlie dynamic H3K9 acetylation during embryonic neurogenesis and in schizophrenia-like animals 32
Endocannabinoid system genes regulation in schizophrenia 32
Dual effects of melatonin on barbiturate-induced narcosis in rats 32
Increased levels of conditioned fear and avoidance behavior coincide with changes in phosphorylation of the protein kinase B (AKT) within the amygdala in a mouse model of extremes in trait anxiety 32
Behavioral and pharmacokinetic profile of indole-derived synthetic cannabinoids JWH-073 and JWH-210 as compared to the phytocannabinoid 19-THC in rats 32
Amnesia induced by beta-amyloid peptide in dopamine D3 knock-out (KO) mice Is affectedby a cannabinoid CB1 receptor antagonist 31
Prenatal influences facilitate the precipitation of a schizophrenia-like phenotype: assessing the role of the endocannabinoid system 31
Stressors affect the response of male and female rats to clomipramine in a model of behavioral despair (forced swim test) 31
Systemic depletion of histone macroH2A1.1 boosts hippocampal synaptic plasticity and social behavior in mice 31
Sex Differences in the Reinstatement of Methamphetamine Seeking after Forced Abstinence in Sprague-Dawley Rats 30
Cognitive effects of SL65.0155, a serotonin 5-HT4 receptor partial agonist, in animal models of amnesia 30
Dopaminergic drugs may counteract behavioral and biochemical changes induced by models of brain injury 30
2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons 30
Phytocannabinoids and schizophrenia: Focus on adolescence as a critical window of enhanced vulnerability and opportunity for treatment 30
Memory performance of dopamine D3 knock-out mice (KO) mice pre-treated with beta-amyloid peptide is affected by cannabinoid CB1 receptor antagonist 29
Prolonged fear incubation leads to generalized avoidance behavior in mice 29
Endocannabinoid system in sexual motivational processes: Is it a novel therapeutic horizon? 29
The Effects of Peripubertal THC Exposure in Neurodevelopmental Rat Models of Psychopathology 28
Role of the endocannabinoid system and vanilloid TRPV1 channels in the phenotype of dopamine D3 receptor knock-out mice 28
“Prescription pattern of antiepileptics in primary care in Italy upon recognition of new indications for reimbursement“. 28
The amnesic effects induced by β-amyloidfragment 1–42 involve cannabinoid neurotransmission in the brain 28
The beta3 adrenoceptor agonist amibegron counteracts stress-induced behavioural and neurobiological changes 28
Fluoxetine Protects Retinal Ischemic Damage in Mice 27
Hippocampal neuroplasticity is involved in the antidepressant-like effects of 5HT4 receptor partial agonist SL 65.0155 27
Endocannabinoid system and mood disorders: Priming a target for new therapies 27
Use of phenylethanolaminotetralines for preparing anxiolytic drugs 27
Dynamic DNA methylation programs persistent adverse effects of early-life stress 26
Nociceptin/orphanin FQ opioid receptor (NOP) selective ligand MCOPPB links anxiolytic and senolytic effects 26
Suppression of Methamphetamine Self-Administration by Ketamine Pre-treatment Is Absent in the Methylazoxymethanol (MAM) Rat Model of Schizophrenia 25
Dysregulation of endocannabinoid system in schizophrenia: the potential role of cannabinoid 1 receptor altered gene expression 25
Enhanced cognitive performance of dopamine D3 receptor "knock-out" mice in the step-through passive-avoidance test: assessing the role of the endocannabinoid/endovanilloid systems 25
Vitamin D and depression in women: a mini-review 25
Are the epigenetic changes predictive of therapeutic efficacy for psychiatric disorders? A translational approach towards novel drug targets 24
D3 dopamine receptor knockout mice: behavioral alteration in experimental models of anxiety 24
Early pharmacological modulation of the endogenous cannabinoid signaling counteracts the phenotype in a rodent developmental disruption model of schizophrenia at adulthood 24
Lack of interaction of endocannabinoids and 5-HT(3) neurotransmission in associative fear circuits of the amygdala: evidence from electrophysiological and behavioural experiments 24
Interacting effects of the MAM model of schizophrenia and antipsychotic treatment: Untargeted proteomics approach in adipose tissue 24
Olanzapine, but not haloperiool, improves cognitive performance in an animal model of amnesia induced by β-amyloid peptides 23
Placebo affects the performance of rats in models of depression: is it a good control for behavioral experiments? 23
Use of phenylethanolaminotetralines for preparing anxiolytic drugs 22
The Dopamine and Cannabinoid Interaction in the Modulation of Emotions and Cognition: Assessing the Role of Cannabinoid CB1 Receptor in Neurons Expressing Dopamine D1 Receptors. 22
Parkin expression in dopamine D3 receptor Knock out mice 22
Leading compounds for the validation of animal models of psychopathology 22
Role of the Endocannabinoid System in Depression: from Preclinical to Clinical Evidence 22
Endocannabinoid system, stress and HPA axis 22
Signaling through cGMP-dependent protein kinase I in the amygdala is critical for auditory-cued fear memory and long-term potentiation 21
Hippocampal expression of BDNF is involved in the behavioral effects of the β3 adrenoceptor agonist, SR58611A 21
D3 dopamine receptor knockout mice tested in the forced swim test: increased sensitivity to different antidepressant drugs 20
Cognitive effects of SL650155, a 5HT4 receptor partial agonist, in animal models of amnesia 20
Cannabinoid receptor type 1 receptors on GABAergic vs. glutamatergic neurons differentially gate sex-dependent social interest in mice 20
Structural and behavioural changes in a rodent developmental disruption model of schizophrenia 19
The dual blocker of FAAH/TRPV1 N-arachidonoylserotonin reverses the behavioral despair induced by stress in rats and modulates the HPA-axis 17
NK 2 receptor: A new target for depression therapy 16
Binge-like alcohol exposure in adolescence: behavioural, neuroendocrine and molecular evidence of abnormal neuroplasticity … and return 16
Metabolic profile of methylazoxymethanol model of schizophrenia in rats and effects of three antipsychotics in long-acting formulation 15
Cannabidiol and the central nervous system: translating into clinics 8
Topically administered NOX4 inhibitor, GLX7013114, is efficacious in treating the early pathological events of diabetic retinopathy 8
Prenatal Exposure to Δ9-Tetrahydrocannabinol Affects Hippocampus-Related Cognitive Functions in the Adolescent Rat Offspring: Focus on Specific Markers of Neuroplasticity 7
Totale 3.184
Categoria #
all - tutte 10.781
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.781

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201934 0 0 0 0 0 0 0 1 4 4 1 24
2019/2020519 193 58 25 7 50 18 37 1 22 2 76 30
2020/2021386 8 22 47 1 136 9 64 6 22 7 44 20
2021/2022668 92 90 7 23 100 11 96 35 33 2 12 167
2022/20231.099 98 51 12 85 87 188 10 192 294 3 45 34
2023/2024251 32 67 26 32 23 53 4 14 0 0 0 0
Totale 3.196